Physician profile
Luis Goity
NPI 1275039802
$1,439.91
in general payments reported to CMS, 2019-2025
8 companies · $31.64 in 2025
The $31.64 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $127 · 2023: $847 · 2024: $435 · 2025: $31.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763 · Consulting Fee: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.16 |
| Consulting Fee | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Templates Ag | $550.00 | 2023 | |
| Balt USA, LLC | $256.90 | 2022-2023 | Prestige Coil System |
| Inari Medical, INC. | $166.36 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sirtex Medical INC | $148.78 | 2024 | Sir-Spheres Microspheres |
| Trisalus Life Sciences, INC. | $140.78 | 2024 | Trinav Infusion System |
| Boston Scientific Corporation | $74.05 | 2024 | Embold Fibered |
| Surmodics, INC. | $71.40 | 2024 | Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy |
| Bard Peripheral Vascular, INC. | $31.64 | 2025 | Covera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Goity listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.